Insider Transactions

AMGEN INC (AMGN) Insider Transactions

Over the last 12 months, 22 AMGEN INC (AMGN) insiders filed 146 SEC Form 4 transactions: $0 in open-market purchases ( 0 distinct buyers) and $29.3M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 146 (1-year window)

Each row is a single Form 4 filing event for AMGN, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-08-13 Khosla Rachna SVP, Business Development Exercise M $203.6K 1,252 $162.6
2026-08-13 Khosla Rachna SVP, Business Development Exercise M $0 1,252 $0.0
2026-08-13 Khosla Rachna SVP, Business Development Sell S $521.4K 1,252 $416.4
2026-08-11 Khosla Rachna SVP, Business Development Sell S $825.1K 2,000 $412.6
2026-08-07 ISHRAK OMAR Grant A $0 85 $0.0
2026-08-07 HOLLEY CHARLES M Grant A $0 103 $0.0
2026-08-07 Drake Michael V Grant A $0 64 $0.0
2026-08-07 Busch Matthew C. VP, Finance & CAO Grant A $0 730 $0.0
2026-08-06 Miller Derek SVP, Human Resources Exercise M $336.4K 2,069 $162.6
2026-08-06 Miller Derek SVP, Human Resources Exercise M $323.2K 1,821 $177.5
2026-08-06 Miller Derek SVP, Human Resources Exercise M $0 2,069 $0.0
2026-08-06 Miller Derek SVP, Human Resources Exercise M $0 1,821 $0.0
2026-08-06 Grygiel Nancy A. SVP & CCO Exercise M $349.6K 1,970 $177.5
2026-08-06 Grygiel Nancy A. SVP & CCO Exercise M $177.3K 1,000 $177.3
2026-08-06 Grygiel Nancy A. SVP & CCO Exercise M $0 1,970 $0.0
2026-08-06 Grygiel Nancy A. SVP & CCO Exercise M $0 1,000 $0.0
2026-08-06 Miller Derek SVP, Human Resources Sell S $832.9K 2,069 $402.5
2026-08-06 Miller Derek SVP, Human Resources Sell S $733.0K 1,821 $402.5
2026-08-06 Grygiel Nancy A. SVP & CCO Sell S $792.3K 1,970 $402.2
2026-08-06 Grygiel Nancy A. SVP & CCO Sell S $402.2K 1,000 $402.2
2026-05-19 MILES AMY E Grant A $0 665 $0.0
2026-05-19 Kullman Ellen Jamison Grant A $0 665 $0.0
2026-05-19 Klotman Mary E. Grant A $0 665 $0.0
2026-05-19 Jacks Tyler Grant A $0 665 $0.0
2026-05-19 ISHRAK OMAR Grant A $0 665 $0.0
2026-05-19 HOLLEY CHARLES M Grant A $0 665 $0.0
2026-05-19 Garland Greg C. Grant A $0 665 $0.0
2026-05-19 ECKERT ROBERT Grant A $0 665 $0.0
2026-05-19 Druker Brian Grant A $0 665 $0.0
2026-05-19 Drake Michael V Grant A $0 665 $0.0
2026-05-19 Austin Wanda M Grant A $0 665 $0.0
2026-05-07 Busch Matthew C. VP, Finance & CAO Other F $13.6K 41 $331.1
2026-05-07 Santos Esteban EVP, Operations Other F $172.8K 522 $331.1
2026-05-07 REESE DAVID M EVP & Chief Technology Officer Other F $184.1K 556 $331.1
2026-05-07 Miller Derek SVP, Human Resources Other F $50.0K 151 $331.1
2026-05-07 Khosla Rachna SVP, Business Development Other F $30.8K 93 $331.1
2026-05-07 Grygiel Nancy A. SVP & CCO Other F $29.1K 88 $331.1
2026-05-07 Griffith Peter H. EVP & CFO Other F $184.1K 556 $331.1
2026-05-07 Graham Jonathan P EVP & Gen. Counsel & Sec. Other F $165.2K 499 $331.1
2026-05-07 Gordon Murdo EVP, Global Commercial Ops Other F $203.6K 615 $331.1
2026-05-07 Bradway Robert A Chairman, CEO and President Other F $688.4K 2,079 $331.1
2026-05-07 Bradner James E. EVP, Research and Development Other F $147.7K 446 $331.1
2026-05-06 Bradner James E. EVP, Research and Development Other F $134.1K 407 $329.6
2026-05-06 Bradway Robert A Chairman, CEO and President Other F $561.0K 1,702 $329.6
2026-05-06 Busch Matthew C. VP, Finance & CAO Other F $16.5K 50 $329.6
2026-05-06 Gordon Murdo EVP, Global Commercial Ops Other F $165.5K 502 $329.6
2026-05-06 Graham Jonathan P EVP & Gen. Counsel & Sec. Other F $134.5K 408 $329.6
2026-05-06 Griffith Peter H. EVP & CFO Other F $165.5K 502 $329.6
2026-05-06 Grygiel Nancy A. SVP & CCO Other F $25.0K 76 $329.6
2026-05-06 Khosla Rachna SVP, Business Development Other F $26.0K 79 $329.6

Showing the most recent 50 of 146 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track AMGN Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for AMGEN INC?

Form 4 is a transaction-level disclosure that corporate insiders (officers, directors, and beneficial owners of more than 10% of a registered class of equity securities) must file with the SEC within two business days of any change in their beneficial ownership of AMGEN INC (AMGN) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of AMGEN INC (AMGN) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.